Feedback
Settings

Settings

Goto Application

1. WO2005113580 - ANTICORONVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND MATERIALS FOR THEIR SYNTHESIS

PermaLink
Publication Number WO/2005/113580
Publication Date 01.12.2005
International Application No. PCT/IB2005/001289
International Filing Date 09.05.2005
Chapter 2 Demand Filed 20.06.2005
IPC
C07K 5/10 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
5Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
04containing only normal peptide links
10Tetrapeptides
A61K 38/07 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
07Tetrapeptides
CPC
A61K 38/21
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
21Interferons ; [IFN]
C07K 5/06191
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
5Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
04containing only normal peptide links
06Dipeptides
06191containing heteroatoms different from O, S, or N
C07K 5/0821
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
5Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
04containing only normal peptide links
08Tripeptides
0821with the first amino acid being heterocyclic, e.g. His, Pro, Trp
C07K 5/0827
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
5Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
04containing only normal peptide links
08Tripeptides
0827containing heteroatoms different from O, S, or N
Applicants
  • PFIZER INC. [US]/[US] (AllExceptUS)
  • HOFFMAN, Robert, Louis [US]/[US] (UsOnly)
  • KANIA, Robert, Steven [US]/[US] (UsOnly)
  • NIEMAN, James, Andrew [CA]/[US] (UsOnly)
  • PLANKEN, Simon, Paul [GB]/[US] (UsOnly)
  • SMITH, George, Joseph, III [US]/[US] (UsOnly)
Inventors
  • HOFFMAN, Robert, Louis
  • KANIA, Robert, Steven
  • NIEMAN, James, Andrew
  • PLANKEN, Simon, Paul
  • SMITH, George, Joseph, III
Agents
  • FULLER, Grover, F., Jr.
Priority Data
60/573,23521.05.2004US
60/575,54028.05.2004US
60/578,17208.06.2004US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) ANTICORONVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND MATERIALS FOR THEIR SYNTHESIS
(FR) COMPOSES ET COMPOSITIONS ANTI-CORONAVIRUS, UTILISATIONS PHARMACEUTIQUES ASSOCIEES ET MATERIAUX POUR LA SYNTHESE DE CES COMPOSES ET COMPOSITIONS
front page image
Abstract
(EN) The invention relates to methods of inhibiting SARS-related coronavirus viral replication activity comprising contacting a SARS-related coronavirus protease with a therapeutically effective amount of a SARS 3C like protease inhibitor of formula (I), and compositions comprising the same.
(FR) L'invention concerne des procédés d'inhibition de l'activité de réplication virale du coronavirus associé au SRAS. Ces procédés consistent à mettre en contact une protéase du coronavirus associé au SRAS avec une quantité thérapeutiquement efficace d'un inhibiteur de protéase de type 3C du SRAS de formule (I). L'invention concerne également des compositions contenant ledit composé.
Latest bibliographic data on file with the International Bureau
# -